With the acquisition, Gland pharma may also get access to global companies like AstraZeneca, Sanofi, Mylan, and Organon. : Several buyout firms including Advent International, Baring Private Equity Asia, Bain Capital, Blackstone, Carlyle and KKR have been approached to buy Fosun-owned Gland Pharma. If the deal goes forward, it will be India's biggest pharma deal, a report by the Economic Times (ET) said. Currently, Fosun owns a 57.86 per cent stake in the Indian generic injectable maker Gland Pharma. Fosun acquired Gland Pharma in 2017 for $1.1 billion. It was listed in 2020 in a Rs 6,480 crore IPO.